Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares traded up 10.5% on Friday . The stock traded as high as C$0.11 and last traded at C$0.11. 572,213 shares were traded during trading, an increase of 353% from the average session volume of 126,331 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Trading Up 31.6 %
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s 50-day moving average is C$0.07 and its two-hundred day moving average is C$0.06. The company has a market cap of C$17.43 million, a P/E ratio of -12.50 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Stock Splits, Do They Really Impact Investors?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is a Secondary Public Offering? What Investors Need to Know
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 Grocery Stocks That Are Proving They Are Still Essential
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
